Sepsis & infection

Determinants of diagnostic yield and scan quality of [18F]FDG PET/CT in critically ill patients suspected of infection or inflammation of unknown origin

Crit CarePublished Retrospective cohort study

Authors' conclusion

[18F]FDG PET/CT has a high diagnostic yield in critically ill patients. Diagnostic yield, scan quality and myocardial suppression are influenced by patient characteristics and preparation.

Study context

Population
Adult ICU patients suspected of infection or inflammation of unknown origin undergoing [18F]FDG PET/CT, four Dutch hospitals (2013–2023)162 indications
Participants
151 patients · 169 scans
Outcome
Diagnostic yield: new conclusive diagnoses and/or therapy changes
Follow-up
Within 72 h
Methodological detailsmulticentre
  • Multicentre

Main finding

As reported in the abstract

Diagnostic yield (per indication)
Adjusted odds ratio (95% CI)
Diabetesfewer new diagnoses
0.35(0.15–0.80)
Partial-body imaging vs Total-body imagingfewer new diagnoses
0.48(0.24–0.99)
Longer pre-scan ICU staypredicted therapy change
1.03(1.01–1.05)
Conclusive diagnosis
109 indications (67%)
New diagnoses
79 (49%)
New diagnoses involving musculoskeletal system
n = 39; 24%
New diagnoses involving respiratory tract
n = 31; 19%
Therapy change
70 indications (43%)

Observational data: associations, not effects.

Secondary outcomes

Scan quality

aOR (CI)
Higher BMIImproved scan quality1.08 (1.00–1.17)
Lower serum creatinineLog-transformed; improved scan quality0.36 (0.20–0.68)

Adequacy of myocardial suppression

aOR (CI)
Male sexSuboptimal myocardial suppression0.45 (0.21–0.96)
Pre-scan unfractionated heparinSuboptimal myocardial suppression0.43 (0.19–0.98)

Original publication

Determinants of diagnostic yield and scan quality of [18F]FDG PET/CT in critically ill patients suspected of infection or inflammation of unknown origin. Crit Care. Published 10 April 2026. doi:10.1186/s13054-026-06005-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.